anaesthetic considerations in cpb by- dr suchit khanduja
DESCRIPTION
ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA MODERATOR-PROF SURINDER SINGH . DEFINITION. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/1.jpg)
ANAESTHETIC CONSIDERATIONS IN CPB
BY- DR SUCHIT KHANDUJA
MODERATOR-PROF SURINDER SINGH
![Page 2: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/2.jpg)
DEFINITION
• “CPB is the technique whereby blood is totally or partially diverted from the heart into a machine with the gas exchange capacity and subsequently returned to the arterial circulation at appropriate pressures & flow rates.”
![Page 3: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/3.jpg)
HISTORICAL ASPECTS
• Legllois (1812) : “circulation might be taken over for short periods”
• Dr.John Gibbon(Philadelphia) 1953 :
“performed ASD repair with the aid of CPB for the 1st time with the survival of patient.”
![Page 4: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/4.jpg)
GOALS OF CPB• To provide a still &
Bloodless Heart with blood flow temporarily diverted to an Extracorporeal Circuit that functionally replaces the Heart & the Lung
![Page 5: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/5.jpg)
GOALS OF CPB
RESPIRATION VentillationOxygenationCIRCULATIONTEMP. REGULATION (Hypothermia)Low blood flowso ed blood trauma ses Body Metabolism.
![Page 6: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/6.jpg)
COMPONENTS OF CPB
• TOTAL CPB : Systemic venous drainage CPB Circuit External oxygenator heat exchanger External pump arterial filterSystemic circulation.
• PARTIAL CPB : Portion of systemic venous return (Rt. Heart) CPB .Undiverted blood Rt. Atrium Rt. Ventricle Pul. Circulation Lt. Atrium & Lt. Ventricle Systemic Circulation.
![Page 7: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/7.jpg)
INTEGRAL COMPONENTS OF extracorporeal circuit
• PUMPS OXYGENATOR Heat exchangerArterial filterCardioplegia delivery systemAortic/atrial/vena caval cannulaeSuction/vent
![Page 8: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/8.jpg)
RESERVOIR
PATIENTARTERIAL
LINEFILTER
ROLLERPUMP
OXYGENATORHEAT
EXCHANGER
![Page 9: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/9.jpg)
![Page 10: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/10.jpg)
ROLLER PUMP
• Most commonly used.• Uses Volume displacement to create
forward blood flow.• Non Pulsatile Blood Flow• By compressing Plastic Tubing b/w Roller &
Backing Plate
![Page 11: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/11.jpg)
• Properly set occlusion causes minimal haemolysis
• Occlusion is 100% in cardioplegia &vent pumps
• Each pump indepedently controlled by a rheostat
• Larger tubing and lesser rotations cause minimal haemolysis
![Page 12: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/12.jpg)
• Resistance= resistance of tubing+oxygenator+heat excyhanger+filter+aortic cannulae+SVR
• Usually line pr. depends on SVR and pump flow rate
• Nl limit is 150-350 mm hg( >250 is seldom accepted)
![Page 13: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/13.jpg)
DISADVANTAGE of producing PULSATILE FLOW
Bubble Formation Damage to Blood Components.
ADVANTAGE :w Improved Tissue Perfusionw Better Preservation of Organ Function (Brain , Kidney)
![Page 14: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/14.jpg)
CENTRIFUGAL PUMP
• Series of CONES that spin & propel blood forward by Centrifugal Force.
• Safe • Reliable• Disposable• Simple to operate.
![Page 15: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/15.jpg)
CENTRIFUGAL PUMP• ADVANTAGEÀ No back pressure when tubing
is temporarily obstructed / kinked
À Doesn’t produce spatulated emboli from compression of the tubing
À Cannot pump large amt.of gas / gas emboli.
À Less blood traumaÀ High vol. output with moderate
pressures
• DISADVANTAGE Inability to generate
pulsatile flow Potential discrepancy b/w
pump speed & actual flow generated.
![Page 16: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/16.jpg)
• Preferred over roller pumps in• Long-term CPB
• In high-risk angioplasty patients
• Ventricular assistance
• Neonatal ECMO
![Page 17: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/17.jpg)
• Pressure-regulated pump• Operates under passive filling
• After&pre-load sensitive
• Pump-chamberof polyurethane+peristaltic pump
• Not yet fully evaluated
![Page 18: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/18.jpg)
OXYGENATOR• Where O2 & CO2 Exchange takes place.• Two Types :
BUBBLE OXYGENATOR
MEMBRANOUS OXYGENATOR
![Page 19: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/19.jpg)
BUBBLE OXYGENATOR
• Gas exchange by directly infusing the gas into a column of systemic venous blood.
• A) OXYGENATING CHAMBERS : bubbles produced by ventilating gas through diffusion plate into venous blood column
• CO2 bubble & oxygen plasma• Larger the No. of Bubbles ; Greater the efficiency of the oxygenator.• Larger bubbles improve removal of CO2 , diffuses 25 times more rapidly in
plasma than O2
• Smaller bubbles are very efficient at oxygenation but poor in co2 removal
![Page 20: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/20.jpg)
![Page 21: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/21.jpg)
DEFOAMING CHAMBER
• Defoaming of frothy blood.
• Large surface area coated with silicone
• This es the Surface Tension of the bubbles causing them to burst.
![Page 22: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/22.jpg)
BUBBLE OXYGENATOR
ADVANTAGE• Easy to assemble• Relatively small
priming Volumes• Adequate oxygenating
capacity• Lower cost.
DISADVANTAGE• Micro emboli• Blood cell trauma• Destruction of plasma
protein due to gas interface.
• Excessive removal of CO2
• Defoaming capacity may get exhausted with time.
![Page 23: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/23.jpg)
![Page 24: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/24.jpg)
MEMBRANOUS OXYGENATOR
• Gas exchange across a thin membrane• Eliminates the need for a bubble-blood contact
& need for a defoamer; so more physiological.• Blood damage is minimum• Ideal for perfusions lasting for >2-3 hours.• 2 types of membrane:• SOLID: Silicone • MICROPOROUS: polypropylene,Teflon
&polyacrylamide
![Page 25: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/25.jpg)
![Page 26: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/26.jpg)
![Page 27: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/27.jpg)
MEMBRANOUS OXYGENATOR
ADVANTAGE• Can deliver Air-O2
mixtures.• Hemolysis• Protein
desaturation• Post-op bleeding• Better platelet
preservation.
DISADVANTAGE• Expensive• Large priming
volume• Prolonged use
pores may get blocked.
![Page 28: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/28.jpg)
![Page 29: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/29.jpg)
CIRCUITS
† Drains Venous Blood by gravity into oxygenator & returns the oxygenated blood under pressure to the systemic circulation.
![Page 30: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/30.jpg)
VENOUS DRAINAGE• Systemic venous blood
(Rt.Heart)Oxygenator byDirect Cannulation of SVC & IVC (Bicaval
Cannulation) thru RA & joined to create a single drainage channel.
Single cannula into RA thru RA appendage.
• Blood flow Oxygenator (Gravity)• Height Difference B/w Venacavae &
Oxygenator > 20-30 cm.
![Page 31: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/31.jpg)
Complications• arrhythmia
• bleeding
• ivc/svc tear
• cannula malposition
• low return
• inadequate height
• malposition
• kink,clamp,air lock
![Page 32: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/32.jpg)
![Page 33: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/33.jpg)
Size of cannula
Adults Children
SVC 28G 24G
IVC 36G 28G
![Page 34: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/34.jpg)
![Page 35: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/35.jpg)
TUBINGS IN THE CIRCUIT
• Non thrombogenic , Chemically Inert to prevent wclottingwTrauma to blood elementswProtein Denaturation
• Smooth Internal Finish• Non Reactable Internal Surface• Durable to withstand high pressure & use of Roller
pump
![Page 36: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/36.jpg)
• Made of • PVC
• Polyurethane
• Silicone• I.D . Ranges from 3/16- 5/8 inches
• HEPARIN BONDED CIRCUITS ARE AVAILABLE
![Page 37: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/37.jpg)
Disadvantages of plain circuits• Activation of platelets/coagulation factors• Post-op consumptive coagulopathyimmune
reactions• More spallation
Heparin coated circuits are• More hemo compatible• Cause less activation of platelets/white cells• Reduce heparin demand
![Page 38: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/38.jpg)
INTRACARDIAC SUCTION
• Blood will enter the heart Coronary venous Return
Retrograde flow in AR.Bronchial Arteries
x CARDIOTOMY SUCTION• Spilled Heparinised Blood is Scavenged &
returned back to patient.• Handheld Suckers are used to return this
blood.
![Page 39: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/39.jpg)
VENTRICULAR VENTING
• LV Venting done to• Keep the operative field clear• Maintain Low LA & Pul.Venous Pressure• Remove air from Cardiac Chamber.
•Blood from LV Reservoir Bag
![Page 40: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/40.jpg)
RESERVOIR BAG
• Collects the blood from VENOUS DRAINAGE & CARDIOTOMY SUCTION DRAIN PASSIVELY
Reservoir Bag Oxygenator Heat exchanger Arterial Filter Patient.
• Volume in the bag should not be allowed to empty to prevent massive emboli.
![Page 41: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/41.jpg)
ARTERIAL RETURN• Ascending Aorta just proximal to Innominate Artery.• Femoral Artery in
Dissecting Aortic AneurysmFor Reoperation Emergency
• Problems of Femoral Cannulation :• Sepsis• Formation of False Aneurysm• Development of Lymphatic Fistula.
![Page 42: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/42.jpg)
ARTERIAL CANNULA
• Is the Narrowest part of the circuit.
• Should be as Short as possible.
• As Large as the diameter of vessel permits.
![Page 43: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/43.jpg)
Complications• Difficult Cannulation
• Intramural Placement
• Air embolism
• Dislodgement of Cannula
• Dissection
• Arch Vessel Cannulation
• Back Wall Injury
![Page 44: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/44.jpg)
• MICROPORE FILTERS:• Remove Particulate Matter (Bone , Tissue , Fat
, Blood Clots etc.)
• Pore Size : 30 – 40
• ULTRAFILTRATION :• Remove the excess fluid from the CPB.
![Page 45: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/45.jpg)
PRIME FLUID
• Ideally close to ECF.• Whole Blood NOT used :
• Homologous Blood Syndrome.• Post Perfusion Bleeding Diathesis• Incompatibility Reactions.• Demand on Blood Banks.• Addition of Priming Fluid HEMODILUTION.
![Page 46: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/46.jpg)
COMPOSITION OF PRIME :
• Balanced salt soln. RL 1250 ml
• Osmotically active agent 100 ml (Mannitol, Dextran 40 , Hexastarch)
• NaHCO3 50ml
• KCl 10ml• Heparin 1ml
![Page 47: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/47.jpg)
PRIMING
• Heme, nonheme
• Decreases viscosity so better flow
• Attenuates increased viscosity by hypothermia
• Alters pharmacodynamics and kinetics of drugs
• Decreases Hb but improves O2 delivery
• Lowest acceptable value 8g/dl
![Page 48: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/48.jpg)
• Prediction of initial haematocrit during CPB
Predicted Hct = Pt. RBC volume before CPB
/ Pt. EBV + CPB prime volume
– EBV • Infants 80-85 ml/kg• Children 75ml/kg• Adult (male) 70ml/kg• Adult (female) 65ml/kg
– 1U packed cells = 0.7 x 350 = 245ml – IU whole blood = 0.4 x 350 = 140ml
![Page 49: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/49.jpg)
• Amount of priming fluid
• CVX CPCV = Pt. BV X PCV + PV X PCV
• PT.BLOOD VOL. x PT. HEMATOCRIT = TARGET HCT X(PRIME VOL. + PT. BLOOD VOL.)
![Page 50: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/50.jpg)
PATHOPHYSIOLOGY OF CPB
• THREE MAJOR PHYSIOLOGICAL ABERRTIONS ARE:
1.LOSS OF PULSATILE FLOW
2.EXPOSURE OF BLOOD TO NON-PHYSIOLOGIC SURFACES & SHEAR STRESSES.
3.EXAGGERATED STRESS RESPONSE.
![Page 51: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/51.jpg)
CIRCULATORY SYSTEM• SVR : Initial Phase SVR i. Blood Viscosity 20 to Hemodilution.ii. Vascular Tone d/t dilution of circulatory catecholaminesAs CPB BP , d/t SVRa) Actual in Vascular C/S area d/t closure of portions of
microvasculature.b) Catecholaminesc) VC d/t hypothermia.
• Cardiac output : flow rate at 2.2-2.4 l/m2/min at 370c.• BP : 0-70 mm Hg.• Venous tone : Close to zero
![Page 52: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/52.jpg)
PULMONARY EFFECT
• Activated neutrophils (elastase &lysosomal enzyme ) accumulate within the lungs during CPB.
• Pul. Venous Pressure , 20 to LAP , es the risk of Pul.Interstitial Edema.* After CPB Pul.Compliance falls & Airway
Resistance leading to Work of Breathing.
![Page 53: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/53.jpg)
CNS CHANGES
• Embolic phenomena : –Air–Preexisting thrombi–Platelet & leucocyte aggregate–Fat globules
• Hemodilution –> mild cerebral edema• CBF when MAP es <40mmHg during CPB
![Page 54: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/54.jpg)
RENAL EFFECT
• MICRO EMBOLI
• Vasoconstrictors
• Ppt. of Plasma Hb in Renal tubules U.O.
• Long term ace inhibitor therapy can result in decline in glomerular filteration pressure
![Page 55: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/55.jpg)
HEMATOLOGIC EFFECT
• RBC : become stiffer & less distensible –Exposed to Non-physiologic surfaces– Hemolysis d/t high flow rates
• WBC : Marked in PMN• PLATELETS : aggregation & dysfunction
thrombocytopenia.
![Page 56: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/56.jpg)
HEMATOLOGIC EFFECT
• PLASMA PROTEIN :Denaturation – Altered enzymatic function– Aggregation of platelets– Altered solubility characteristics– Release of lipids– Absorption of denatured proteins into cell
membranes.
![Page 57: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/57.jpg)
NEUROENDOCRINE RESPONSE TO CPB:
• Serum Catecholamines : –Both ADR & NA –D/t reflexes from Baroreceptors &
Chemoreceptors in the Heart & Lungs when the organs are excluded from circulation.
• ADH,Cortisol , Glucagons & GH are
![Page 58: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/58.jpg)
INDUCTION OF ANAESTHESIA
• Choice depends on haemodynamic status1. High dose opioid anesthesia2. Total intravenous anesthesia3. Mixed iv/inhalational agent anesthesia
![Page 59: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/59.jpg)
• High dose opioid• Fentanyl -50-100mic/kg,sufentanil 15-25mic/kgADV-Faster extubationDisadvantage-1. Prolonged respiratory depression2. Chest wall ridgidity3. Patient awareness4. Inability to control hypertensive response
![Page 60: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/60.jpg)
Total iv anaesthesia• Propofol 1-2 mg/kg with infusion of 50-
100mic/kg/min• Remifentanil 0-1mic/kg bolus followed by .25-
1mic/kg/min• TCI may be used
![Page 61: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/61.jpg)
Mixed IC/Inhalational anesthesia• Interest grew after studies on protective effect of
volatile agents on myocardium• Propofol,thiopentone,midazolam may all be given• Opioid given in smaller dosages with inhalational
agent at .5-1.5 MAC• Isoflurane,sevoflurane and desflurane used• N2O not used because of its tendency to expand
bubbles in intravasular compartment during CPB
![Page 62: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/62.jpg)
• Isoflorane.desflorane and sevoflorane cause dose dependent vasodilation.
• Also lead to ischaemic preconditioning.• N20 usually avoided .• Radial artery is cannulated.• Contralateral femoral also used as conduit.• Cvp catheter or PA catheter or both
introduced.• Bladder catheter,temp. probe and TEE probe
positioned.
![Page 63: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/63.jpg)
PRE-CPBTwo stages
– High level of stimulation • Skin incision, sternal split, sternal spread, aortic
dissection cannulation. • Increase HR, BP, ischemia, dysrhythmias, HF
– Low level of stimulation • Preincision, Radial artery harvesting, LIMA
dissection, CPB venous cannulation. • Decrease HR, BP, ischemia, dysrhythmias
![Page 64: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/64.jpg)
• All injection ports should be accessible• Monitoring lines should be well secured • Confirm zero of all transducers • Evaluate cardiac status by TEE (placed before heparin).• Once patient stabilized
– ABG, ACT, BSL, Serum electrolytes
• Antibiotics• Antifibrinolytics
– Aprotinin, EACA, Transexamic acid
![Page 65: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/65.jpg)
• Pre-incision, sternal split– Supplemental - Narcotics, relaxants, hypnotics, inhaled agents.
– Ensure adequate depth of anaesthesia.
• Redo case – Lateral CXR provides a clue to potential problems
– Longer time required than routine
– Femoral vessels to be prepared
– External defibrillator
– Adequate volume replacement – crystalloids, colloids, blood and blood products.
![Page 66: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/66.jpg)
HEPARIN
• Jay Mclean-1916, William Howell • N-sulfated-D-Glucosamine& L-iduronic acid• strongest acid, anionic, negative charged • Heterogenous compound, mol wt 5000 – 30000 (most chains
12000-19000). • UFH dose should not be specified by weight but by units.• 1 USP of heparin activity is the quantity that prevents 1 ml of
citrated sheep”s plasma from clotting for 1 hr after addition of calcium.
• Standard heparin is UNFRACTIONATED HEPARIN (UFH ).
![Page 67: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/67.jpg)
• Heparan• found in CT, contains more of glucuronic acid >20% N-
acetylation.
• Abundant in tissues rich in mast cells • liver, lungs, intestines • skin, lymph nodes, thymus lesser sources.
• Two sources • Bovine lung• Porcine intestinal mucosal ( most commercial prep ,
40000 lbs yield 5kg heparin)
![Page 68: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/68.jpg)
• Pharmacokinetics & dynamics:• 3 compartment model describes heparin kinetics
• Rapid initial clearance from endothelial cell uptake• Saturable clearance seen in lower doses due to uptake by RES & its
endoglycosidases, endosulfatases & uptake into monocytes.• Exponential decay seen at higher doses due to renal clearance via tubular
secretion.• Metabolism:
• 50%- RES• 50%- Renal elimination
• Actions:• Exerts its actions via AT-III which inhibits thrombin, IXa, Xa.• UFH accelerates the formation of thrombin-AT complex 2000 X, Xa-AT
complex 1200X• LMWH preferentially inhibits Xa
![Page 69: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/69.jpg)
HEPARIN RESISTANCE/ ALTERED HEPARIN RESPONSIVENESS:
• Pts previously receiving heparin exhibit tachyphylaxis, diminished response to full anticoag doses of UFH for CPB.
Risk Factors:• Elderly/ neonates
• Previous heparin therapy
• OCP/ Pregnancy
• Thrombocytosis
• Congenital AT-III deficiency• Hemodilution
• IABP• Shock• STK• Infective endocarditis• Ventricular aneurysm with
thrombus• Consumptive coagulopathy
![Page 70: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/70.jpg)
• Dose:• 3-4 mg/ kg• 300-400 u/ kg• given in central vein or directly into RA• use HDR• always confirm with ACT
UFH chelates Ca, large bolus- decline in BP due to decrease in SVR & preload.
Immunologic effects-30-50% pts of cardiac surgery have heparin Abs by the time of hospital discharge
![Page 71: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/71.jpg)
• Arterial sample in 3-5 min
• Give additional heparin as needed to maintain ACT >300 s in normothermic and >400 s in hypothermic CPB
• Monitor ACT every 30 min or more frequently if pt.is heparin resistant
• If ACT goes <300 s give additional 50 u/kg heparin
![Page 72: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/72.jpg)
ACTs
• <180 s - life threatening
• 180-300 s -highly questionable
• >600 s –risky and unwise
![Page 73: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/73.jpg)
• Individual anticoag response to heparin varies , hence measurement of individual anticoag response to heparin for CPB is warranted. Usually heparin effect is measured and not its plasma levels.
TREATMENT
– Additional heparin
– AT-III concentrate (1000 u increases AT-III levels by 30%
– rhAT trials on (75 U/ kg)
– FFP ( risk of infection transmission, reserved for rare refractory cases)
![Page 74: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/74.jpg)
HEPARIN REBOUND
• pts develop clinical bleeding assoc with prolongation of coagulation times due to reappearance of circulating heparin.
CAUSES – late release of heparin sequestered in tissues– delayed return of heparin to circulation from extracellular
space via lymphatics– clearance of an unrecognized endothelial heparin
antagonist– more rapid clearance of protamine to heparin.
• Incidence-50%• Can occur as soon as 1 hr after prota adm
![Page 75: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/75.jpg)
TREATMENT:
• Clinical bleeding does not always accompany heparin rebound.
• If + -additional supplemental protamine.
• Larger initial doses may decrease likelihood but risk of adverse cardiovasc sequelae & anticoag effects of protamine.
• Use HDR to calculate heparin.
![Page 76: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/76.jpg)
HIT
• Heparin normally binds to platelet memb at GP Ib and aggregates normal platelets by releasing ADP.
• Type-I– moderately reversible– Prolongation of BT
• Type-II– Occ severe & progressive thrombocytopenia (<1 lac)– Accom by severe fatal thrombosis– Drop in platelet count > 30-50% over several days in a pt receiving or
finished receiving heparin.
• Heparin dependent Abs usually IgG present, lower titres during therapy but rise once therapy ceases.
![Page 77: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/77.jpg)
DIAGNOSIS:
• Incidence 1-3%
• Dose related but can occur even with heparin flush or heparin bonded intravascular catheters.
• Usually 3-15 days after heparin but can occur within hours in a pt previously exposed to heparin
• Decrease in platelet counts
• Serotonin release assay- pt plasma + donor platelets containing radiolabelled serotonin + heparin.
• ELISA for Ab to hep-PF4 complex.
![Page 78: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/78.jpg)
Treatment
• PC not indicated
• Discontinue heparin
• Start alternative anticoag
• Surgery for thrombosis
• Aspirin, ticlopidine, dipyridamole block adhesion and activation and PF4 release
• Delay surgery to wait for Abs to regress
• Plasmapheresis
• Heparin substitutes
![Page 79: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/79.jpg)
HEPARIN SUBSTITUTES
![Page 80: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/80.jpg)
CANNULATION
• Aortic cannula first – Maintain SBP to 90-100– MAP 60 –80– Excessive lowering – damage to posterior wall – Largest possible size
• Check line pressures • Sandblasting effect • Coanda effect
![Page 81: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/81.jpg)
Complications
• Difficult Cannulation
• Intramural Placement
• Air embolism
• Dislodgement of Cannula
• Dissection
• Arch Vessel Cannulation
• Back Wall Injury
![Page 82: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/82.jpg)
• Venous Cannulation – Single stage
• Atrial
• Bicaval
– Two stage • Atriocaval
– Peripheral
• size is important
![Page 83: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/83.jpg)
Complications
• arrhythmia
• bleeding
• ivc/svc tear
• cannula malposition
• low return
• inadequate height
• malposition
• kink,clamp,air lock
![Page 84: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/84.jpg)
HYPOTHERMIA
• Decreases BMR VO2, VCO2
• Provides organ protection and safety margin • Decreases excitatory NT (glutamate) release• Decreases rate of enzymatic reaction
• Q10 - change in reaction rate for 100C (2-3)
• Can use non sanguinous primes and lower flows
![Page 85: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/85.jpg)
• Increases SVR, PVR • Decreases blood trauma • Decreases blood flow to all tissues but also req.• Decreases HR
• Dysrhythmia occur
– Nodal, VPC, AF, VF, blocks, asystole
• Decreases ventilation
• Left ward shift of ODC
• Increases dead space – no effect on gas exchange
![Page 86: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/86.jpg)
• Increases renal vascular resistance
• Decreases renal blood flow
• Decreases tubular reabsorption
• Urine flow may be increased
• Hepatic blood flow decreased
• Decreased metabolic and excretory liver function
• Marked hyperglycemia – decrease insulin increased catechol
• Affects coagulation by platelet dysfunction and inhibition of coagulation factor.
![Page 87: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/87.jpg)
Mild 32 –350CModerate - 26-310CDeep 18-260CProfound - <180C
• Cooling / rewarming facilitated by increasing pump flow rates and dilators.
• Gradient < 5-100C, never exceed 400C.
![Page 88: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/88.jpg)
NORMOTHERMIC CPB• Warm cardioplegia
– Better myo substrate use– (L) ODC shift avoided – Diastolic arrest produces greatest reduction in MVO2
– Continuous CP attenuates reperfusion injury • No need for rewarming • Earlier extubation • Lower SVR so higher flow rates, vasoconstrictors
Ideal temperature – indeterminate • Tepid CPB 32-340C• Terminate CPB 34-350C
![Page 89: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/89.jpg)
MEAN ARTERIAL PRESSURE
• maintain 70-90 @ normothermia• 50-70 mm Hg 30-32°C• 30-40 mm Hg @ <30°C
• Higher pressures- increased non coronary collateral flow
• Maintain adequate flows• SVR-
– increased by phenylephrine, noradr– decreased by NTG, SNP, anaesthetics
![Page 90: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/90.jpg)
Sub-groups needing higher pressure
• Severe atherosclerosis
• Advanced age
• Hypertension
• Diabetes
![Page 91: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/91.jpg)
CPB INFLAMMATORY RESPONSE
• Blood contact with non endothelial surface
• Complement system, monocyte- macrophage system, cytokines, endotoxins, freeradicals,metalloproteinases
• Systemic inflammatory response to bypass
![Page 92: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/92.jpg)
MONITORING
PATIENT• ECG
• Arterial/ Perfusion pr
• Coagulation-ACT,TEG
• SpO2 ,EtCO2
• ABG
• BSL
• EEG, BIS
• CVP/ PAC • Temperature• Urine output• Se electrolytes• Hb, Hct• TEE• SjvO2
•
![Page 93: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/93.jpg)
PUMP
Inline blood gas monitoring
Venous oximetry
Line pressure
Temperature monitoring
Flow
Reservoir volume
Bubbles
![Page 94: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/94.jpg)
CARDIOPLEGIARoute• antegrade
aortic root, ostial maintain root pressure 50-100 mm Hg
• retrograde coronary sinus maintain coronary sinus pressure 40-60 mm Hg
Temp • warm• tepid• cold
Interval• continuous • intermittent
![Page 95: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/95.jpg)
Vehicle• blood• crystalloid
• total dose is 20-30 ml/ kg• target myocardial temp. is 10-15ºC • repeat every 20-30 min• dose is usually ½ the induction dose with ½ the
potassium conc. of the induction soln.
![Page 96: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/96.jpg)
AIMS OF CARDIOPLEGIC ARREST
• induce arrest as quickly as possible
• provide oxygenation
• maintaining cellular integrity by maintaining Na-K ATPase
• provide energy substrates for metabolism
• maintain osmolarity to prevent cellular edema
• possess buffering capability,oxygen free-radical scavenging capacity (best by blood )
• hypothermia helps in decreasing oxygen demand
![Page 97: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/97.jpg)
ULTRAFILTRATION
• hydrostatic pressure• increased by increasing perfusion pressures or by
applying vacuum on the effluent side of the memb• pore size is imp (10-35 A°) (20000 Da)• Alb, Hb, fibrinogen, blood cells remain back
• MUF– after separation from CPB– blood from aortic cannula thru hemoconc to RA
![Page 98: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/98.jpg)
• CUF– performed during rewarming– volume removed is based on volume in CPB circuit– Limited in pediatric pt. (<10kg,small intravasc vol)
& stopped once CPB is off
• High Volume Zero UF– modification of CUF– UF volume is replaced with equal volume of
crystalloid
![Page 99: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/99.jpg)
Advantages:• removal of free water • preservation of hemostasis• increases Hb,plat counts, fibrinogen, albumen• removes proinflammatory mediators-complements,
TNF, IL-1, IL-6,IL-8• removal of C-3a-decreases PVR, improves
oxygenation, faster extubation• improves post-CPB hemodynamics- lower HR, inc
SBP, higher cardiac index, better diastolic compliance• decreases cerebral edema• improves renal function post CPB
![Page 100: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/100.jpg)
WEANING FROM CPBC V P
Cold Ventilation Predictor
Conduction Visualisation Pressure
Cardiac output Vapourizer Pressors
Cells Volume expander Pacer
Calcium Potassium
Coagulation Protamine
![Page 101: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/101.jpg)
PROTAMINE• Meischer 1868, Hagedorn & colleagues 1936• contains many positive charges, nearly 2/3rd arginine• Chargaff & Olson- neutralizing drug• salmon milt• Stable without refrigeration for several weeks• Available as sulfate & chloride salts ( Chloride has more
rapid onset of action)
Actions:• Formation of complexes with sulfate groups of heparin
form the basis for antidote effect• Neutralizes AT effect of heparin far better than anti Xa
effect, hence poor ability to neutralize LMWHs
![Page 102: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/102.jpg)
Advantages:
• removal of free water • preservation of hemostasis• increases Hb,plat counts, fibrinogen, albumen• removes proinflammatory mediators-complements,
TNF, IL-1, IL-6,IL-8• removal of C-3a-decreases PVR, improves
oxygenation, faster extubation• improves post-CPB hemodynamics- lower HR, inc
SBP, higher cardiac index, better diastolic compliance• decreases cerebral edema• improves renal function post CPB
![Page 103: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/103.jpg)
• Recommended doses to neutralize heparin vary widely
• lot of controversy regarding optimal prota-hep ratio, dose to prevent rebound & whether to calculate prota dose based on total amt of hep given or amt remaining in the pt.
• Normally 1.3-1.5 X heparin doses, 75% given foll CPB & 25% foll reinfusion of pump blood
• Best to use protamine titration tests
![Page 104: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/104.jpg)
GUIDELINES FOR USE:• Add to 50 ml clear infusion & adm infusion over 10-15min
• Additional doses of undiluted prota given @20mg/ min
• Slow adm decreases Type I & Type III adverse reactions but Type II can occur at any delivery rate
• No screening test in DM, risk is only 0.6%
• In pts with fish allergy skin testing is predictive,give 1mg prota diluted in 50ml over 10min & if no adverse response give full dose
• In pts with prior reaction to prota skin testing, RAST, ELISA appropriate, test dose as before, use prota alternatives
![Page 105: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/105.jpg)
Adverse Reactions
![Page 106: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/106.jpg)
TREATMENT
• Slow adm limits Type III since large complexes do not form• Stop prota infusion• Stop all cardiodepressant drugs• IV fluids, Calcium• Antihistaminics• Hydrocortisone/ Aminophylline• Adm of heparin bolus in an attempt to decrease hep-prota
complex size• Ionodilators- Milrinone, Isoproterenol• Avoid rechallenge with prota• Reinstitute CPB
![Page 107: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/107.jpg)
TERMINATION FROM BYPASS
• Ventilation has been re established.• Venous return to pump decreased by
clamping the line.• If cardiac performance non optimal then
additional blood from pump can be taken.• When BP,CO,Preload optimal arterial pump
stopped,and venous canula removed.• Aortic canula not to be removed until test
dose of protamine given.
![Page 108: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/108.jpg)
OFF PUMP CORONARY ARTERY BYPASS SURGERY
• OPCAB accounts fot 20-30% of all CAB surgeries.• Performed through median sternotomy.• Bypass grafts include right and left mammary
arteries,saphenous veins,and radial arteries.• Special sternal retractors used.• Fixation devices stabalise the area of heart.• Verticlisation of apex done.
• Surgical visualisation with help of blower.• Distal anastomoses then performed.
![Page 109: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/109.jpg)
ANAESTHETIC CONSIDERATIONS
• Revolve around haemodynamic perturbations.
• Surface stabaliser and apical displacement device associated with dec. CO,Sv and MAP.
• The above can also lead to distortion of mitral valve annulus.
• Rewarming not done.
![Page 110: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/110.jpg)
MONITORING
• Standard ASA• Arterial Catheter• Central Venous A• Ischemia Monitoring
- EKG ST trend - PA Catheter? - TEE?
![Page 111: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/111.jpg)
MONITORING DIFFICULTIES
![Page 112: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/112.jpg)
• Haemodynamic changes treated with volume expansion.
• Blood transfusion for high risk patients.• Hypotension can be treated with
inotropes,volume expansion.• NTG to be used cautiously.• Worsening haemodynamic status or ecg
changes warrrant insertion of intracoronary stents.
• Conversion of OPCAB to CABG with CPB an option.
![Page 113: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/113.jpg)
ADVANTAGES OF OPCAB
• There are several advantages to beating heart surgery from the anesthesiologist's perspective:
• The patient is extubated early, is not severely anemic, is awake and breathing on his/her own.
• There are no cannulation sites in large vessels which can potentially bleed.
• Less hemodilution.• Coagulopathies are uncommon.
![Page 114: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/114.jpg)
OTHERS…
• Shorter postoperative hospital stays.• Shorter time with ventilatory support.• Less blood loss and need for transfusions.• Less likelihood of low output syndrome.• Reduced systemic inflammatory response.• Fewer arrhythmia and neurologic
postoperative complications.• Potential cost savings.
![Page 115: ANAESTHETIC CONSIDERATIONS IN CPB BY- DR SUCHIT KHANDUJA](https://reader035.vdocuments.net/reader035/viewer/2022062521/568164f0550346895dd75b26/html5/thumbnails/115.jpg)
THANX!!